Generate Biomedicines, Clinical-Stage Generative Biology Company Designing AI-Engineered Protein Therapeutics, Files for Nasdaq IPO

Kulicke and Soffa (NASDAQ:KLIC) Beats Expectations in Strong Q4 But Inventory Levels Increase

Should You Buy the 3 Highest-Paying Dividend Stocks in the Nasdaq?

What Wall Street Is Saying About This Nervous Market

We're booking profits in 2 Dow stocks riding double-digit gains to start 2026

Nasdaq plunges more than 2%, and these 10 names are fanning the flames